Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Stroke|July 30, 2005
REACH: clinical feasibility of a rural telestroke networkDavid C Hess, Samuel Wang, William Hamilton, et al.
Journal of Biomedical Informatics|May 18, 2005
Primary care physician time utilization before and after implementation of an electronic health record: a time-motion studyLisa Pizziferri, Anne F Kittler, Lynn A Volk, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|January 18, 2020
Cuff-Less Blood Pressure Monitoring with a 3-Axis AccelerometerEric Chang, Samuel Wang, Chung-Kuan Cheng, et al.
Molecular Biology of the Cell|September 21, 2022
Tau differentially regulates the transport of early endosomes and lysosomesLinda Balabanian, Dominique V Lessard, Karthikeyan Swaminathan, et al.
Journal of Neural Engineering|September 3, 2021
Designing and pilot testing a novel high-definition transcranial burst electrostimulation device for neurorehabilitationShun-Min Samuel Wang, Yi-Jing Huang, Jia-Jin Jason Chen, et al.
Journal of Translational Medicine|July 16, 2026
Extracellular vesicles as a liquid biopsy for amyotrophic lateral sclerosis: a systematic review and meta-analysisMagdalena M Bolsinger, Nandhana Vivek, Javraj Singh, et al.
Melanoma Research|January 5, 2024
Evaluating the efficacy of combination and single-agent immunotherapies in real-world patterns of disease progression and survival of metastatic melanoma patientsBrian Ko, Kevin Tao, Lachlan Brennan, et al.
Nature Communications|July 12, 2024
Glucose-6-phosphate dehydrogenase maintains redox homeostasis and biosynthesis in LKB1-deficient KRAS-driven lung cancerTaijin Lan, Sara Arastu, Jarrick Lam, et al.
Biorxiv : the Preprint Server for Biology|October 24, 2023
G6PD Maintains Redox Homeostasis and Biosynthesis in LKB1-Deficient KRAS-Driven Lung CancerTaijin Lan, Sara Arastu, Samuel Wang, et al.
Circulation|May 2, 2007
Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations)John D Day, Rahul N Doshi, Peter Belott, et al.
Pageof 6